Focus: NuVasive is a mid-cap medical device company headquartered in San Diego with 5,001-10,000 employees, focusing on spine surgery and orthopedic solutions. The company operates as a public entity (ticker: GMED) with a diversified portfolio of surgical devices and biologics.
Profile data last refreshed 21h ago · AI intelligence enriched 2w ago
Hot — 937 jobs added in 30d
Net +819 (937 new, 118 removed). Aggressive expansion phase.
NuVasive is a stable, device-focused growth platform best for professionals seeking engineering, commercial, and clinical operations roles in orthopedic/spine surgery—less ideal for drug development specialists or early-stage discovery researchers.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for NuVasive
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from NuVasive's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles